Katherine Vega Stultz's Insider Trades & SAST Disclosures

Katherine Vega Stultz's most recent trade in Kronos Bio Inc was a trade of 68,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kronos Bio Inc
Katherine Vega Stultz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 68,000 0 - - Stock Option (Right to Buy)
Kronos Bio Inc
Katherine Vega Stultz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 34,000 0 - - Stock Option (Right to Buy)
Kronos Bio Inc
Katherine Vega Stultz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 20 Jun 2025 7,079 0 - - Stock Option (Right to Buy)
Kronos Bio Inc
Katherine Vega Stultz Director 25 Jun 2024 34,000 34,000 - - Stock Option (Right to Buy)
Kronos Bio Inc
Katherine Vega Stultz Director 22 Jun 2023 7,079 7,079 - - Stock Option (Right to Buy)
Kronos Bio Inc
Katherine Vega Stultz Director 10 Apr 2023 68,000 68,000 - - Director Stock Option (Right to Buy)
Graphite Bio Inc
Katherine Vega Stultz CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 209,846 209,846 - - Stock Option (right to buy)
Graphite Bio Inc
Katherine Vega Stultz CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 99,753 99,753 - - Stock Option (right to buy)
Graphite Bio Inc
Katherine Vega Stultz CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 89,934 89,934 - - Stock Option (right to buy)
Graphite Bio Inc
Katherine Vega Stultz CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 19,763 19,763 - - Series B Preferred Stock
Graphite Bio Inc
Katherine Vega Stultz CHIEF OPERATING OFFICER 13 Jan 2021 19,763 0 - - Series B Preferred Stock
Graphite Bio Inc
Katherine Vega Stultz CHIEF OPERATING OFFICER 13 Jan 2021 8,126 216,020 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades